Literature DB >> 20685034

Surgical resection of osteolytic calvarial lesions: clinicopathological features.

Bujung Hong1, Elvis J Hermann, Rüdiger Klein, Joachim K Krauss, Makoto Nakamura.   

Abstract

OBJECTIVE: Osteolytic calvarial lesions are infrequent findings. Some cases are found incidentally during cancer staging or subsequent to unspecific symptoms. There are no standardized algorithms for the treatment of such lesions. Thus, the aim of this study was to describe the clinicopathological features and surgical outcome in various osteolytic calvarial lesions.
MATERIAL AND METHODS: The clinical presentation, radiological imaging findings, surgical treatment and histopathological findings of 36 patients who underwent surgery for an osteolytic calvarial lesion at our institution between 1998 and 2008 were reviewed.
RESULTS: Thirty-six osteolytic calvarial lesions were identified in 20 men and 16 women. Mean age at diagnosis was 37 years. Ten patients were children younger than 15 years. Five lesions were detected during cancer staging. Complete removal of the calvarial lesions was achieved in all patients without complications. The most common histopathological diagnosis was metastasis (n=9), Langerhans-cell histiocytosis (n=9), and intraosseous hemangioma (n=5). In two asymptomatic patients, histopathological findings revealed metastases of a previously unknown tumor. In two other patients known to suffer from cancer, histopathological findings indicated intraosseous hemangioma and intraosseous meningioma, respectively. Reconstruction of the calvarial defect was performed in 24 cases with poly-methyl-methacrylate and with titanium mesh in 1 case.
CONCLUSIONS: Osteolytic calvarial lesions can be found in any age group. The histopathological examination reveals various entities, and in some instances it was not concurrent with a primary malignancy. Because surgical morbidity is low, we recommend complete resection of osteolytic calvarial lesions with reconstruction when feasible.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20685034     DOI: 10.1016/j.clineuro.2010.07.010

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  6 in total

1.  Langerhans cell histiocytosis with seborrheic eczema of the scalp and extensive calvarial involvement.

Authors:  Satoshi Tsutsumi; Shintaro Nakajima; Hisayuki Oda; Yukimasa Yasumoto
Journal:  Childs Nerv Syst       Date:  2016-01-27       Impact factor: 1.475

Review 2.  Fronto-orbito-ethmoidal intradiploic meningiomas: A case study with systematic review.

Authors:  Antonio Crea; Gianluca Grimod; Gianluca Scalia; Mariarosaria Verlotta; Lucio Mazzeo; Giorgio Rossi; Davide Mattavelli; Vittorio Rampinelli; Sabino Luzzi; Giannantonio Spena
Journal:  Surg Neurol Int       Date:  2021-09-30

3.  Primary Intraosseous Osteolytic Meningioma with Aggressive Clinical Behaviour: Clinico-Pathologic Correlation and Proposed New Clinical Classification.

Authors:  Nazmin Ahmed; Gianluca Ferini; Moududul Haque; Giuseppe Emmanuele Umana; Gianluca Scalia; Bipin Chaurasia; Atul Vats; Asifur Rahman
Journal:  Life (Basel)       Date:  2022-04-06

4.  Calvarial Langerhans cell histiocytosis in an adult presenting rapid growth.

Authors:  Hiroki Sugiyama; Satoshi Tsutsumi; Akane Hashizume; Kiyotaka Kuroda; Natsuki Sugiyama; Hideaki Ueno; Hisato Ishii
Journal:  Surg Neurol Int       Date:  2022-08-05

5.  POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, multiple myeloma and skin changes) with cranial vault plasmocytoma and the role of surgery in its management: a case report.

Authors:  Julio Plata Bello; Victor Garcia-Marin
Journal:  J Med Case Rep       Date:  2013-10-18

Review 6.  Calvarial lesions: overview of imaging features and neurosurgical management.

Authors:  Isabella Nasi-Kordhishti; Johann-Martin Hempel; Florian Heinrich Ebner; Marcos Tatagiba
Journal:  Neurosurg Rev       Date:  2021-03-22       Impact factor: 3.042

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.